Ralph G Zinner

Algorithmic Guided Screening of Drug Combinations of Arbitrary Size for Activity against Cancer Cells

Li Mao, Paul Damien, Elmira Popova, 2022 .

Assessing PIK3CA and PTEN in early-phase trials with PI3K/AKT/mTOR inhibitors.

Razelle Kurzrock, J Jack Lee, Rajyalakshmi Luthra, 2014, Cell reports.

Phase 1 Clinical and Pharmacokinetics Evaluation of Oral CI-1033 in Patients with Refractory Cancer

Ralph G Zinner, Dong M Shin, D. Shin, 2005, Clinical Cancer Research.

Combining Erlotinib and Cetuximab Is Associated with Activity in Patients with Non–Small Cell Lung Cancer (Including Squamous Cell Carcinomas) and Wild-Type EGFR or Resistant Mutations

Razelle Kurzrock, Ralph G Zinner, Apostolia M Tsimberidou, 2013, Molecular Cancer Therapeutics.